1 INTRODUCTION 19
1.1 OBJECTIVES OF THE STUDY 19
1.2 MARKET DEFINITION 19
1.3 MARKET SCOPE 20
1.3.1 MARKETS COVERED 20
1.3.2 YEARS CONSIDERED FOR THE STUDY 20
1.4 CURRENCY 21
1.5 LIMITATIONS 21
1.6 STAKEHOLDERS 21

2 RESEARCH METHODOLOGY 22
2.1 RESEARCH DATA 22
2.1.1 SECONDARY DATA 24
2.1.1.1 Key data from secondary sources 24
2.1.2 PRIMARY DATA 25
2.1.2.1 Key data from primary sources 26
2.2 MARKET SIZE ESTIMATION 27
2.2.1 PRODUCT-BASED MARKET ESTIMATION 28
2.2.2 PRIMARY RESEARCH VALIDATION 29
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 30
2.4 RESEARCH ASSUMPTIONS 31
2.5 RESEARCH LIMITATIONS 31

3 EXECUTIVE SUMMARY 32

4 PREMIUM INSIGHTS 36
4.1 3D BIOPRINTING MARKET OVERVIEW 36
4.2 3D BIOPRINTING MARKET SHARE, BY COMPONENT AND REGION 37
4.3 3D BIOPRINTING MARKET, BY MATERIAL, 2019 VS. 2024 (USD MILLION) 38
4.4 3D BIOPRINTING MARKET, BY END USER, 2019 VS. 2024 (USD MILLION) 39
4.5 GEOGRAPHIC SNAPSHOT OF THE 3D BIOPRINTING MARKET 40

5 MARKET OVERVIEW 41
5.1 INTRODUCTION 41
5.2 3D BIOPRINTING APPROACHES 41
5.2.1 BIOMIMICRY 41
5.2.2 AUTONOMOUS SELF-ASSEMBLY 41
5.2.3 MINI-TISSUE BUILDING BLOCKS 41
5.3 MARKET DYNAMICS 42
5.3.1 DRIVERS 42
5.3.1.1 Increasing use of 3D bioprinting in the pharmaceutical and cosmetology industries 42
5.3.1.2 Rising public and private funding to support bioprinting research activities 43
5.3.1.3 Technological advancements in the 3D bioprinting industry 44
5.3.2 RESTRAINTS 45
5.3.2.1 Dearth of skilled professionals 45
5.3.2.2 High development & production costs 45
5.3.2.3 Lack of regulatory guidelines governing 3D bioprinting 45
5.3.3 OPPORTUNITIES 46
5.3.3.1 Rising demand for organ transplants 46
5.3.3.2 Growing awareness of 3D bioprinting 46
5.3.3.3 Growing demand for regenerative medicine & stem cell research 47
5.3.4 CHALLENGES 48
5.3.4.1 Socioethical concerns related to the use of 3D bioprinted products 48
5.3.4.2 High cost of 3D bioprinting 48
5.3.4.3 Process control & understanding 48

6 3D BIOPRINTING MARKET, BY COMPONENT 49
6.1 INTRODUCTION 50
6.2 3D BIOPRINTERS 50
6.2.1 3D BIOPRINTERS MARKET, BY TECHNOLOGY 50
6.2.1.1 Microextrusion bioprinting 51
6.2.1.1.1 Increasing research in the field of microextrusion is fueling the adoption of this technology 51
6.2.1.2 Inkjet 3D bioprinting 53
6.2.1.2.1 High cell viability and low cost have resulted in the increased demand for inkjet 3D bioprinting 53
6.2.1.3 Laser-assisted bioprinting 54
6.2.1.3.1 Laser-assisted bioprinting is one of the highest-resolution bioprinting technologies available in the 3D bioprinting industry 54
6.2.1.4 Magnetic 3D bioprinting 55
6.2.1.4.1 Accuracy and speed in the formation and processing of cultured tissues are the major advantages associated with magnetic 3D bioprinting 55
6.2.1.5 Other technologies 56
6.3 BIOINKS 57
6.3.1 NATURAL BIOINKS 58
6.3.1.1 Natural bioinks are the most commonly preferred bioinks in the
3D bioprinting process 58
?
6.3.2 HYBRID BIOINKS 59
6.3.2.1 Hybrid bioinks possess high mechanical strength and great biocompatibility 59
6.3.3 SYNTHETIC BIOINKS 60
6.3.3.1 Improved mechanical strength and consistency offered by synthetic bioinks to drive market growth 60

7 3D BIOPRINTING MARKET, BY MATERIAL 61
7.1 INTRODUCTION 62
7.2 LIVING CELLS 62
7.2.1 ETHICAL ISSUES ASSOCIATED WITH THE USE OF LIVING CELLS IN ORGAN DEVELOPMENT TO HAMPER MARKET GROWTH 62
7.3 HYDROGELS 63
7.3.1 DYNAMIC PROPERTIES OF HYDROGELS ARE SUPPORTING THEIR INCREASED USE IN 3D TISSUE ENGINEERING AND BIOMEDICAL APPLICATIONS 63
7.4 EXTRACELLULAR MATRICES 64
7.4.1 ECM HAS EMERGED AS A PROMISING TOOL IN TISSUE ENGINEERING 64
7.5 OTHER BIOMATERIALS 65

8 3D BIOPRINTING MARKET, BY APPLICATION 67
8.1 INTRODUCTION 68
8.2 RESEARCH APPLICATIONS 68
8.2.1 DRUG RESEARCH 69
8.2.1.1 Drug research segment to register the highest growth during the forecast period 69
8.2.2 REGENERATIVE MEDICINE 70
8.2.2.1 Growing demand for organ transplants to support market growth 70
8.2.3 3D CELL CULTURE 71
8.2.3.1 Rising focus on developing alternatives to animal testing to support market growth 71
8.3 CLINICAL APPLICATIONS 72
8.3.1 SKIN 73
8.3.1.1 Growing number of aesthetic and reconstruction surgeries to propel market growth 73
8.3.2 BONE & CARTILAGE 74
8.3.2.1 Increasing incidence of musculoskeletal conditions to drive the demand for bone grafts 74
8.3.3 BLOOD VESSELS 75
8.3.3.1 Increasing research activities focused on the 3D bioprinting of blood vessels is the major factor driving market growth 75
8.3.4 OTHER CLINICAL APPLICATIONS 76
?

9 3D BIOPRINTING MARKET, BY END USER 78
9.1 INTRODUCTION 79
9.2 RESEARCH ORGANIZATIONS & ACADEMIC INSTITUTES 79
9.2.1 RESEARCH ORGANIZATIONS & ACADEMIC INSTITUTES ARE THE FASTEST-GROWING END USERS OF 3D BIOPRINTING 79
9.3 BIOPHARMACEUTICAL COMPANIES 80
9.3.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE THE ADOPTION OF 3D BIOPRINTING AMONG BIOPHARMACEUTICAL COMPANIES 80
9.4 HOSPITALS 81
9.4.1 3D PRINTING OFFERS A CUSTOMIZED SURGICAL PLANNING TOOL FOR HOSPITALS 81

10 3D BIOPRINTING MARKET, BY REGION 83
10.1 INTRODUCTION 84
10.2 NORTH AMERICA 84
10.2.1 US 89
10.2.1.1 The US dominates the global 3D bioprinting market 89
10.2.2 CANADA 93
10.2.2.1 Government initiatives to support the growth of the 3D bioprinting market in Canada 93
10.3 EUROPE 96
10.3.1 GERMANY 101
10.3.1.1 Increasing demand for organ transplants to drive market growth 101
10.3.2 UK 104
10.3.2.1 Increase in funding and grants to support research activities related to 3D bioprinting in the UK 104
10.3.3 FRANCE 107
10.3.3.1 Growing cosmetics industry in France to propel the adoption of 3D bioprinting technologies 107
10.3.4 REST OF EUROPE 111
10.4 ASIA PACIFIC 114
10.4.1 JAPAN 119
10.4.1.1 Strong research base and government support to drive the growth of the 3D bioprinting market in Japan 119
10.4.2 CHINA 122
10.4.2.1 The market in China is projected to register significant growth owing to rising regenerative medicine research 122
10.4.3 INDIA 125
10.4.3.1 Initiatives to raise awareness and develop novel products to support market growth in India 125
10.4.4 REST OF ASIA PACIFIC 129
10.5 REST OF THE WORLD 132
10.5.1 LATIN AMERICA 135
10.5.1.1 Growing medical tourism to contribute to the growth of the 3D bioprinting market in the region 135
10.5.2 MIDDLE EAST & AFRICA 138
10.5.2.1 Lack of awareness and underdeveloped infrastructure to hamper market growth 138

11 COMPETITIVE LANDSCAPE 142
11.1 INTRODUCTION 142
11.2 MARKET RANKING ANALYSIS 142
11.3 COMPETITIVE SCENARIO 143
11.4 COMPETITIVE LEADERSHIP MAPPING 145
11.5 VENDOR INCLUSION CRITERIA 145
11.6 VENDOR DIVE 146
11.6.1 VISIONARY LEADERS 146
11.6.2 INNOVATORS 146
11.6.3 DYNAMIC DIFFERENTIATORS 146
11.6.4 EMERGING COMPANIES 146
12 COMPANY PROFILES 149
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.1 ADVANCED SOLUTIONS LIFE SCIENCES 149
12.2 ALLEVI INC. 150
12.3 ASPECT BIOSYSTEMS LTD. 152
12.4 CELLINK 154
12.5 CYFUSE BIOMEDICAL K.K. 159
12.6 DIGILAB, INC. 160
12.7 ENVISIONTEC 161
12.8 GESIM 163
12.9 NANO3D BIOSCIENCES, INC. 164
12.10 ORGANOVO HOLDINGS, INC. 165
12.11 POIETIS 168
12.12 REGENHU 170
12.13 REGENOVO BIOTECHNOLOGY CO., LTD. 171
12.14 ROKIT HEALTHCARE 172
12.15 TEVIDO BIODEVICES 173
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
13 APPENDIX 174
13.1 DISCUSSION GUIDE 174
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS? SUBSCRIPTION PORTAL 180
13.3 AVAILABLE CUSTOMIZATIONS 182
13.4 RELATED REPORTS 182
13.5 AUTHOR DETAILS 183